A new University of Arizona Health Sciences study found women on hormone therapy were up to 58% less likely to develop neurodegenerative diseases including Alzheimer’s disease, and reduction of risk varied by type and route of hormone therapy and duration of use. The findings could lead to the development of a precision medicine approach to preventing neurodegenerative diseases.
The study, published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions, found that women who underwent menopausal hormone therapy for six years or greater were 79% less likely to develop Alzheimer’s and 77% less likely to develop any neurodegenerative disease.
